Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Radiation Oncology
Published in: Radiation Oncology 1/2019

Open Access 01-12-2019 | Vestibular Schwannoma | Letter to the Editor

Hearing loss after radiosurgery-blame it on Cochlear dose or the radiation tool!

Authors: Harsh Deora, Manjul Tripathi

Published in: Radiation Oncology | Issue 1/2019

Login to get access

Abstract

While sudden hearing loss after stereotactic radiosurgery has been demonstrated in some cases a recent article by Linge et al. and have demonstrated the need for further discussion on this topic. We attempt to delineate the fact that the type of dosing regimen or technology used will not affect the hearing or radio-graphical control outcomes and thus should not be a consideration while administering treatment. Also we discuss the role of location of the lesion and vascularity and potential new therapies for this unexpected outcome after radiosurgery.
Literature
1.
van Linge A, van Os R, Hoekstra N, et al. Progression of hearing loss after LINAC-based stereotactic radiotherapy for vestibular schwannoma is associated with cochlear dose, not with pre-treatment hearing level. Radiat Oncol. 2018;13(1):253. Published 2018 Dec 24. doi:https://​doi.​org/​10.​1186/​s13014-018-1202-z.
2.
Tuleasca C, George M, Faouzi M, Schiappacasse L, Leroy HA, Zeverino M, et al. Acute clinical adverse radiation effects after gamma knife surgery for vestibular schwannomas. J Neurosurg. 2016;125:73–82.CrossRef
3.
Germano IM, Sheehan J, Parish J, et al. Congress of neurological surgeons systematic review and evidence-based guideline on the role of radiosurgery and radiation therapy in the management of patients with vestibular schwannomas. Neurosurgery. 2018;82(2):00.CrossRef
4.
Combs SE, Welzel T, Kessel K, et al. Hearing preservation after radiotherapy for vestibular schwannomas is comparable to hearing deterioration in healthy adults and is accompanied by local tumor control and a highly preserved quality of life (QOL) as patients’ self-reported outcome. Radiother Oncol. 2013;106(2):175–80.CrossRef
5.
Hasegawa T, Kida Y, Kato T, Iizuka H, Yamamoto T. Factors associated with hearing preservation after gamma knife surgery for vestibular schwannomas in patients who retain serviceable hearing. J Neurosurg. 2011;115(6):1078–86.CrossRef
6.
Baschnagel AM, Chen PY, Bojrab D, et al. Hearing preservation in patients with vestibular schwannoma treated with gamma knife surgery. J Neurosurg. 2013;118(3):571–8.CrossRef
7.
Boari N, Bailo M, Gagliardi F, et al. Gamma knife radiosurgery for vestibular schwannoma:clinical results at long-term follow-up in a series of 379 patients. J Neurosurg. 2014;121(suppl):123–42.CrossRef
8.
Franzin A, Spatola G, Serra C, et al. Evaluation of hearing function after gamma knife surgery of vestibular schwannomas. Neurosurg Focus. 2009;27(6):E3.CrossRef
9.
Moffat DA, Baguley DM, von Blumenthal H, Irving RM, Hardy DG. Sudden deafness in vestibular schwannoma. J Laryngol Otol. 1994;108:116–9.CrossRef
10.
Sauvaget E, Kici S, Kania R, Herman P, Tran Ba Huy P. Sudden sensorineural hearing loss as a revealing symptom of vestibular schwannoma. Acta Otolaryngol. 2005;125:592–5.CrossRef
11.
Gevaert T, Levivier M, Lacornerie T, Verelen D, Engels B, Reynaert N, Tournerl K, Duchateau M, Reynders T, Depuvdt T, Collen C, Lartigau E, Ridder MD. Dosimetric comparision of different treatment modalities for stereotactic radiosurgery of arteriovenous malformations and acoustic neuromas. Radiother Oncol. 2013;106:192–7.CrossRef
Metadata
Title
Hearing loss after radiosurgery-blame it on Cochlear dose or the radiation tool!
Authors
Harsh Deora
Manjul Tripathi
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Radiation Oncology / Issue 1/2019
Electronic ISSN: 1748-717X
DOI
https://doi.org/10.1186/s13014-019-1390-1

Other articles of this Issue 1/2019

Radiation Oncology 1/2019 Go to the issue

Research

Preliminary result of definitive radiotherapy in patients with non-small cell lung cancer who have underlying idiopathic pulmonary fibrosis: comparison between X-ray and proton therapy

Research

Prediction of VMAT delivery accuracy with textural features calculated from fluence maps

Research

Calculating the individualized fraction regime in stereotactic body radiotherapy for non-small cell lung cancer based on uncomplicated tumor control probability function

Methodology

Development of a high-throughput γ-H2AX assay based on imaging flow cytometry

Review

Radiological diagnosis of brain radiation necrosis after cranial irradiation for brain tumor: a systematic review

Research

Dosimetric factors associated with long-term patient-reported outcomes after definitive radiotherapy of patients with head and neck cancer